| ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
| 49452 | BY55_MOUSE | O88875; Q8C9H4 | Cd160 {ECO:0000303|PubMed:18193050, ECO:0000312|MGI:MGI:1860383} | CD160 antigen; Natural killer cell receptor BY55; CD160 {ECO:0000303|PubMed:18193050} | 54215 |
| 49451 | BY55_HUMAN | A0A0B4J2A1; B8PRF2; O95971; Q5T2V6 | CD160 {ECO:0000303|PubMed:16809620, ECO:0000312|HGNC:HGNC:17013} | CD160 antigen; Natural killer cell receptor BY55; CD160 {ECO:0000303|PubMed:16809620} | 11126 |
| 49450 | BXX_CLOBO | P0DPK1 | | Botulinum neurotoxin type X; BoNT/X; Bontoxilysin-X; LC; 3.4.24.69 {ECO:0000269|PubMed:28770820}; HC | 0 |
| 49449 | BXWO_WEIOS | A0A069CUU9 | | Putative botulinum-like toxin Wo {ECO:0000303|PubMed:27443638}; BoNT/Wo {ECO:0000303|PubMed:27443638}; 3.4.24.69 {ECO:0000269|PubMed:27443638} | 0 |
| 49448 | BXRB_AGRCO | O09210 | | Bombyxin-related peptide B; ABRP | 0 |
| 49447 | BXRA_AGRCO | O09208; O09209 | | Bombyxin-related peptide A; ABRP | 0 |
| 49446 | BXLB_EMENI | C8VEA1; Q5ATH9 | bxlB | Exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 2868685 |
| 49445 | BXLB_ASPTN | Q0CB82 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 4354040 |
| 49444 | BXLB_ASPOR | Q2TYT2 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 0 |
| 49443 | BXLB_ASPFU | Q4WFI6 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 3506129 |
| 49442 | BXLB_ASPFN | B8NYD8 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 0 |
| 49441 | BXLB_ASPFC | B0Y0I4 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 0 |
| 49440 | BXLB_ASPCL | A1CCL9 | bxlB | Probable exo-1,4-beta-xylosidase bxlB; 3.2.1.37; 1,4-beta-D-xylan xylohydrolase bxlB; Beta-xylosidase bxlB; Xylobiase bxlB | 4705939 |
| 49439 | BXL7_ARATH | Q8VZG5; Q9SGZ5 | BXL7 | Probable beta-D-xylosidase 7; AtBXL7; 3.2.1.- | 844141 |
| 49438 | BXL6_ARATH | Q8GZ32; Q9LXA8 | BXL6 | Probable beta-D-xylosidase 6; AtBXL6; 3.2.1.- | 830921 |
| 49437 | BXL5_ARATH | Q9LJN4 | BXL5 | Probable beta-D-xylosidase 5; AtBXL5; 3.2.1.- | 821499 |
| 49436 | BXL4_ARATH | Q56WR7; Q9FLG1 | BXL4 | Beta-D-xylosidase 4; AtBXL4; 3.2.1.37 | 836578 |
| 49435 | BXL3_ARATH | Q56WQ6; Q9LXD6 | BXL3 | Beta-D-xylosidase 3; AtBXL3; 3.2.1.-; Alpha-L-arabinofuranosidase; 3.2.1.55 | 830833 |
| 49434 | BXL2_ARATH | Q94KD8; Q9FWY2 | BXL2 | Probable beta-D-xylosidase 2; AtBXL2; 3.2.1.- | 837940 |
| 49433 | BXL1_ARATH | Q9FGY1 | BXL1 | Beta-D-xylosidase 1; AtBXL1; 3.2.1.-; Alpha-L-arabinofuranosidase; 3.2.1.55 | 834996 |
| 49432 | BXJ_ENTS3 | A0A242DI27 | | Botulinum-like toxin eBoNT/J {ECO:0000303|PubMed:29323697}; eBoNT/J {ECO:0000303|PubMed:29323697}; LC; 3.4.24.69 {ECO:0000305}; HC | 0 |
| 49431 | BXI1_YEAST | D6W0P0; P48558; Q6B2Q1 | BXI1 | Bax inhibitor 1; BH3 domain-containing protein BXI1 | 855411 |
| 49430 | BXI1_SCHPO | O74888 | bxi1 | Bax inhibitor 1; BH3 domain-containing protein bxi1 | 2539556 |
| 49429 | BXG_CLOBO | Q60393 | botG | Botulinum neurotoxin type G; BoNT/G {ECO:0000303|PubMed:8268233}; Bontoxilysin-G; LC; 3.4.24.69 {ECO:0000269|PubMed:7910017}; HC | 0 |
| 49428 | BXG1_BOMMO | O61271 | BBXG1 | Bombyxin G-1; BBX-G1 | 100169726 |
| 49427 | BXF_CLOBO | P30996 | botF | Botulinum neurotoxin type F; BoNT/F {ECO:0000303|PubMed:7764998}; Bontoxilysin-F; LC; 3.4.24.69 {ECO:0000269|PubMed:8505288}; HC | 0 |
| 49426 | BXF_CLOBL | A7GBG3; Q79AH9 | F {ECO:0000312|EMBL:ABS41202.1} | Botulinum neurotoxin type F; BoNT/F {ECO:0000303|Ref.1}; Bontoxilysin-F; LC; 3.4.24.69; HC | 0 |
| 49425 | BXF1_BOMMO | P91896; P91897 | BBXF1 | Bombyxin F-1; BBX-F1 | 100146110 |
| 49424 | BXE_CLOBU | P30995 | | Botulinum neurotoxin type E; BoNT/E; Bontoxilysin-E; LC; 3.4.24.69; HC | 0 |
| 49423 | BXE_CLOBO | Q00496; Q45862 | botE {ECO:0000303|PubMed:1541280} | Botulinum neurotoxin type E; BoNT/E {ECO:0000303|PubMed:8408542}; Bontoxilysin-E; LC; 3.4.24.69 {ECO:0000269|PubMed:8243676}; HC | 0 |
| 49422 | BXEN_CLOBU | Q06366 | | Non-toxic nonhemagglutinin type E; NTNHA; Botulinum neurotoxin type E non-toxic component | 0 |
| 49421 | BXEN_CLOBO | P46082 | ent-120 | Non-toxic nonhemagglutinin type E; NTNHA; Botulinum neurotoxin type E non-toxic component | 0 |
| 49420 | BXE1_BOMMO | O18329; P21808 | BBXE1 | Bombyxin E-1; BBX-E1; 4K-prothoracicotropic hormone IV; 4K-PTTH-IV; Bombyxin IV | 100146109 |
| 49419 | BXD_CBDP | P19321 | botD | Botulinum neurotoxin type D; BoNT/D; Bontoxilysin-D; LC; 3.4.24.69 {ECO:0000269|PubMed:8175689}; HC | 0 |
| 49418 | BXDN_CBDP | Q9LBR2 | ntnha | Non-toxic nonhemagglutinin type D; NTNHA; Botulinum neurotoxin type D non-toxic component | 0 |
| 49417 | BXD1_BOMMO | O01954; P26736 | BBXD1 | Bombyxin D-1; BBX-D1; 4K-prothoracicotropic hormone; 4K-PTTH | 100169725 |
| 49416 | BXC_CBCP | P18640 | | Botulinum neurotoxin type C; BoNT/C; Bontoxilysin-C1; BoNT/C1 {ECO:0000303|PubMed:2204031}; Botulinum neurotoxin type C1; LC; 3.4.24.69 {ECO:0000269|PubMed:7737992}; HC | 3772941 |
| 49415 | BXCN_CBCP | P46081 | | Non-toxic nonhemagglutinin type C; NTNHA; ANTP139; Botulinum neurotoxin type C non-toxic component; Botulinum neurotoxin type C1 non-toxic component | 3772940 |
| 49414 | BXC2_BOMMO | P26735 | BBXC2 | Bombyxin C-2; BBX-C2; 4K-prothoracicotropic hormone; 4K-PTTH | 100147697 |
| 49413 | BXC1_BOMMO | P15410 | BBXC1 | Bombyxin C-1; BBX-C1; 4K-prothoracicotropic hormone; 4K-PTTH | 100147698 |
| 49412 | BXB_CLOBO | P10843; P10844 | botB {ECO:0000303|PubMed:1514783} | Botulinum neurotoxin type B; BoNT/B; Bontoxilysin-B; LC; 3.4.24.69 {ECO:0000269|PubMed:1331807}; HC | 0 |
| 49411 | BXB_CLOBK | B1INP5 | botB | Botulinum neurotoxin type B; BoNT/B; Bontoxilysin-B; LC; 3.4.24.69; HC | 0 |
| 49410 | BXB9_BOMMO | P26743 | BBXB9 | Bombyxin B-9; BBX-B9; 4K-prothoracicotropic hormone; 4K-PTTH | 0 |
| 49409 | BXB8_BOMMO | P26742 | BBXB8 | Bombyxin B-8; BBX-B8; 4K-prothoracicotropic hormone; 4K-PTTH | 100169718 |
| 49408 | BXB7_BOMMO | P26741; Q17195 | BBXB7 | Bombyxin B-7; BBX-B7; 4K-prothoracicotropic hormone; 4K-PTTH | 100169716 |
| 49407 | BXB6_BOMMO | P26740 | BBXB6 | Bombyxin B-6; BBX-B6; 4K-prothoracicotropic hormone; 4K-PTTH | 100169723 |
| 49406 | BXB5_BOMMO | P26739 | BBXB5 | Bombyxin B-5; BBX-B5; 4K-prothoracicotropic hormone; 4K-PTTH | 100169724 |
| 49405 | BXB4_BOMMO | P26738 | BBXB4 | Bombyxin B-4; BBX-B4; 4K-prothoracicotropic hormone; 4K-PTTH | 100169720 |
| 49404 | BXB3_BOMMO | P26737 | BBXB3 | Bombyxin B-3; BBX-B3; 4K-prothoracicotropic hormone; 4K-PTTH | 0 |
| 49403 | BXB2_SAMCY | P33722 | SBXB2 | Bombyxin B-2 homolog | 0 |
